Page last updated: 2024-10-28

miltefosine and EHS Tumor

miltefosine has been researched along with EHS Tumor in 3 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Research Excerpts

ExcerptRelevanceReference
" A dose-response relationship was seen after daily oral treatment with complete suppression of tumor growth at doses of 46."1.27Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). ( Berger, MR; Eibl, H; Engel, J; Hilgard, P; Schumacher, W; Stekar, J; Unger, C; Voegeli, R, 1988)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stekar, J2
Hilgard, P2
Klenner, T1
Zeisig, R1
Rudolf, M1
Eue, I1
Arndt, D1
Voegeli, R1
Engel, J1
Schumacher, W1
Eibl, H1
Unger, C1
Berger, MR1

Other Studies

3 other studies available for miltefosine and EHS Tumor

ArticleYear
Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:3

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzo(a)pyrene; Cycl

1995
Influence of hexadecylphosphocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vitro.
    Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:2

    Topics: Animals; Lipopolysaccharides; Liposomes; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice,

1995
Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:9

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benzopyrenes; Choline; Cyclophosphamide; Dose-Response Re

1988